Skip to main content

Table 1 General characteristics of chronic central serous chorioretinopathy patients who were good and poor responders to photodynamic therapy

From: The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study

 

Good responder group

Poor responder group

p value

Age

50.7 ± 10.1 years (range 34–82)

55.2 ± 13.3 years (range 26–73)

0.08*

Gender (M/F)

59/17

21/4

0.4

Mean duration of the disease

17.5 ± 12.7 months (range 7–80 months)

15.7 ± 8.4 months (range 7–41 months)

0.5*

Mean baseline BCVA

0.49 ± 0.28 decimals (range 0.01–1.0)

0.37 ± 0.25 decimals (range 0.03–1.0)

0.06*

Mean baseline FT

329 ± 79 microns (range 197–575 microns)

301 ± 57 microns (range 207–399 microns)

0.1*

  1. M/F male/female, BCVA best corrected visual acuity, FT foveal thickness
  2. * Independent-samples T test
  3. Chi square test